Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 22, 2026Translational PsychiatryOpen Access

Relationship between fecal short-chain fatty acids (SCFAs) and microbial SCFA pathways with depressive symptoms in Dutch adults

View Full Paper
Ask AI
Bookmark
Share

Authors

VKVera KorenblikTBThomaz F. S. BastiaanssenIHIrina M. de Haas

Discussion

Loading...

Member takes

Overview

Cohort study finds no conclusive link between fecal short-chain fatty acids and depressive symptoms in adults, suggesting metabolic factors like blood pressure may influence gut-brain signaling.

Key Points

  • To examine whether fecal short-chain fatty acid concentrations and microbial metabolic pathways are associated with depressive symptoms, and whether systolic blood pressure moderates these relationships.
  • Analyzed 200 adults (<50 years old) from the HELIUS cohort in the Netherlands, matched on age, sex, and BMI across high and low systolic blood pressure groups.
  • Quantified fecal short-chain fatty acid concentrations using high-performance liquid chromatography and inferred metabolic pathways from 16S rRNA gene sequencing mapped to gut-brain modules.
  • Evaluated depressive symptoms using the Patient Health Questionnaire-9 and modeled associations using multivariable negative binomial regression adjusted for demographic, lifestyle, and clinical covariates.
  • In the high systolic blood pressure group, higher depressive symptom severity was initially associated with lower acetate concentrations, but this did not remain statistically significant after multiple-testing correction (IRR = 0.82, 95% CI [0.69–0.96], p = 0.016, p-adjusted = 0.063).
  • No significant associations were observed between depressive symptoms and other fecal short-chain fatty acid concentrations, ratios, or predicted microbial synthesis and degradation pathways in either blood pressure group.

Cite This Study

Korenblik et al. (2026) studied this question.

synapsesocial.com/papers/6a895ec3ca7ade938187ce2ahttps://doi.org/10.1038/s41398-026-04296-9
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Short-chain fatty acids in schizophrenia: are they affected by a depressive state?2024
  2. 2Alterations of short-chain fatty acids in depression and effects of probiotics/prebiotics interventions on levels and clinical symptoms: a systematic review and meta-analysis2026 · 3 citations
  3. 3Does the association between short-chain fatty acids and depressive symptoms vary with age? A large population-based study2024
  4. 4Circulating Short-Chain Fatty Acid (SCFA) Profiles as a Biomarker of Gut-Brain Axis Dysfunction: A Meta-Analysis for the SCFA Signature in Major Depression2026 · 3 citations
  5. 5Fecal Short-Chain Fatty Acids (SCFAs) and Their Role in Metabolic Disorders: A Systematic Review2025